According to Heska Corporation 's latest financial reports the company's current EPS (TTM) is C-$2.66. In 2022 the company made an earnings per share (EPS) of C-$2.66 a decrease over its 2021 EPS that were of C-$0.14.
Year | EPS | Change |
---|---|---|
2023 (TTM) | C-$2.58 | -2.9% |
2022 | C-$2.66 | 1830% |
2021 | C-$0.14 | -94.19% |
2020 | C-$2.37 | 805.26% |
2019 | C-$0.26 | -123.75% |
2018 | C$1.10 | -43.26% |
2017 | C$1.94 | -9.03% |
2016 | C$2.13 | 93.75% |
2015 | C$1.10 | 81.82% |
2014 | C$0.61 | -309.52% |
2013 | C-$0.29 | -195.45% |
2012 | C$0.30 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | C$15.02 | -665.28% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | C$17.01 | -740.21% | ๐บ๐ธ USA |
![]() Petco WOOF | C-$0.33 | -87.56% | ๐บ๐ธ USA |
![]() Pfizer PFE | C$1.91 | -172.02% | ๐บ๐ธ USA |
![]() Merck MRK | C$9.50 | -457.38% | ๐บ๐ธ USA |
![]() Novartis NVS | C$8.85 | -433.16% | ๐จ๐ญ Switzerland |
![]() Zoetis ZTS | C$7.68 | -389.12% | ๐บ๐ธ USA |